The incorporation of additional clinical studies, especially prospective ones with larger, ethnically diverse prospective cohorts [47], and exploring other relevant metrics like HbA1c, β‐hCG levels, fasting glucose, and insulin resistance markers, will further validate the causative link between PAPP‐A levels and GDM. The gene discussed is PAPPA; the disease is Insulin resistance.